The discovery of the IL-23/IL-17 immunologic pathway was a key to expand our knowledge about the pathogenesis of psoriasis and develop new targeted therapeutic agents about psoriasis as well [17, 37]. The gene discussed is IL17A; the disease is psoriasis.